Celldex Therapeutics, Inc.

CLDX · Nasdaq · SIC 2835: In Vitro & In Vivo Diagnostic Substances · Market Cap: $2.5B · 198 employees
338
SEC Filings
$38.51
Close 2026-09-15
198
Employees

Business Summary

Celldex Therapeutics, Inc. is a biopharmaceutical company focused on mast cell biology, developing therapeutic monoclonal and bispecific antibodies for severe inflammatory, allergic, and autoimmune diseases. Its lead candidate, Barzolvolimab (CDX-0159), a KIT receptor inhibitor, is in Phase 3 trials for Chronic Spontaneous Urticaria and Phase 2 trials for Prurigo Nodularis and Atopic Dermatitis. Its bispecific pipeline includes CDX-622, targeting TSLP and SCF for inflammatory diseases.

Latest Stock Quote

CLDX 2026-09-15 $38.51 O:$39 H:$39.19 L:$37.74 Vol:0.7M VWAP:$38.2673
origin leaf: null

Next Earnings

expected 2026-12-22

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-252025-12-310001104659-26-019652EDGAR78K words
2025-02-272024-12-310001410578-25-000216EDGAR73K words
2024-02-262023-12-310001410578-24-000076EDGAR69K words
2023-02-282022-12-310001104659-23-026701EDGAR—
2022-02-282021-12-310001104659-22-028070EDGAR—
2021-03-292020-12-310001104659-21-043161EDGAR—
2020-03-262019-12-310001047469-20-001809EDGAR—
2019-03-072018-12-310001047469-19-000992EDGAR—
2018-03-072017-12-310001047469-18-001363EDGAR—
2017-03-142016-12-310001047469-17-001564EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-062026-06-300001104659-26-091984EDGAR24K words
2025-11-102025-09-300001104659-25-109137EDGAR24K words
2025-08-072025-06-300001410578-25-001610EDGAR23K words
2025-05-082025-03-310001410578-25-001111EDGAR21K words
2024-11-062024-09-300001410578-24-001766EDGAR22K words
2024-08-082024-06-300001410578-24-001219EDGAR21K words
2024-05-062024-03-310001410578-24-000593EDGAR19K words
2023-11-022023-09-300001410578-23-002169EDGAR20K words
2023-08-082023-06-300001410578-23-001588EDGAR20K words
2023-05-042023-03-310001104659-23-055992EDGAR—
2022-11-092022-09-300001104659-22-116466EDGAR—
2022-08-082022-06-300001104659-22-087222EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-220001104659-26-109465EDGAR2K words
2026-08-060001171843-26-005316EDGAR3K words
2026-07-150001104659-26-083880EDGAR1K words
2026-04-020001104659-26-038882EDGAR25K words
2026-02-250001171843-26-001098EDGAR3K words
2025-11-100001171843-25-007179EDGAR3K words
2025-08-190001104659-25-080248EDGAR2K words
2025-08-070001171843-25-005181EDGAR3K words
2025-06-060001104659-25-057066EDGAR1K words
2025-05-080001171843-25-002980EDGAR2K words

338 total filings indexed. 306 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

ACHV — ACHIEVE LIFE SCIENCES, INC. TKNO — Alpha Teknova, Inc. NNNN — Anbio Biotechnology AWHL — Aspira Women's Health Inc. BMRA — BIOMERICA INC BZYR — BURZYNSKI RESEARCH INSTITUTE INC CDIO — Cardio Diagnostics Holdings, Inc. IDXX — IDEXX LABORATORIES INC /DE

Tags

chronic-spontaneous-urticaria chronic-inducible-urticaria prurigo-nodularis atopic-dermatitis inflammatory-and-autoimmune-diseases allergic-diseases

Company Identity

CIK0000744218
TickerCLDX
ExchangeNasdaq
SIC2835: In Vitro & In Vivo Diagnostic Substances
IncorporatedDE
Websitehttps://www.celldex.com
Listed1986-05-15

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: af05c344521dd2a4bd1e9dbcdf6c84548408f01572aab825273ac6fdbc1f2f38
parent: 3a892a96648e53b2f043e08a584df3efdcbd523b968244ae30e0215af16513ff
content hash: e396254273cb814b1d57a5c8c109417c3bb1f41e028d49c66b564cab66b784f9
signed: 2026-09-28T19:00:46.044Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up CLDX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on CLDX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/CLDX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.